Is tartrazine consumption dangerous for people, especially those with a history of allergies or asthma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tartrazine Consumption Safety in Allergic Individuals

Tartrazine consumption is generally safe for most people, but may pose risks for a small subset of individuals with specific sensitivities, particularly those with aspirin sensitivity or certain types of asthma. 1

Safety Profile of Tartrazine

  • Tartrazine (FD&C Yellow No. 5) is a commonly used food additive and colorant present in many foods, beverages, and medications 2
  • The prevalence of tartrazine intolerance is estimated to be less than 0.12% in the general population 3
  • Routine tartrazine exclusion is not beneficial for most patients, except for the very few individuals with proven sensitivity 4

Risk Assessment for Specific Populations

Asthmatic Individuals

  • Multiple controlled studies have failed to demonstrate significant effects of tartrazine on asthma control in most patients 4
  • A Cochrane review found that in none of the studies did tartrazine challenge or avoidance significantly alter asthma outcomes 4
  • The 2020 NIH Asthma Management Guidelines do not mention tartrazine avoidance as a recommended strategy for asthma management 1

Cross-Sensitivity with Aspirin

  • Some individuals with aspirin sensitivity may experience cross-reactivity with tartrazine 2
  • This cross-sensitivity is most common in patients with:
    • Aspirin-exacerbated respiratory disease
    • NSAID sensitivity
    • Chronic urticaria

Potential Reactions

When reactions do occur, they may manifest as:

  • Urticaria (hives)
  • Asthma exacerbations
  • Angioedema
  • Rhinitis symptoms

Evidence from Challenge Studies

A double-blind placebo-controlled study in 26 atopic adults found:

  • No significant cutaneous, respiratory, or cardiovascular reactions after administration of 35 mg of tartrazine compared to placebo 5
  • No statistical differences between placebo and tartrazine in various physiological parameters 5

Recommendations for Clinical Practice

  1. General Population: No specific restrictions needed for tartrazine consumption

  2. For Individuals with Suspected Sensitivity:

    • Consider tartrazine avoidance only in patients with documented sensitivity through proper challenge testing
    • Advise patients to check food and medication labels for the presence of tartrazine (listed as E102 in Europe or Yellow #5 in the US)
    • Be particularly vigilant with patients who have:
      • Known aspirin or NSAID sensitivity
      • Chronic idiopathic urticaria
      • Poorly controlled asthma with suspected food additive triggers
  3. For Healthcare Providers:

    • Be aware that many pharmaceutical preparations may contain tartrazine 6
    • Consider tartrazine-free alternatives for patients with documented sensitivity

Conclusion

The evidence does not support routine avoidance of tartrazine for most individuals, including those with asthma or allergies. The link between tartrazine consumption and adverse reactions is often overestimated, and the pathogenic mechanisms remain poorly understood 3. Only patients with confirmed tartrazine sensitivity through proper challenge testing should consider avoidance strategies.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tartrazine sensitivity.

American family physician, 1990

Research

Tartrazine exclusion for allergic asthma.

The Cochrane database of systematic reviews, 2001

Research

[Pharmaceutical preparations which contain tartrazine].

Allergologia et immunopathologia, 1981

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.